{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:16:41Z","timestamp":1778116601716,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.vaccine.2008.02.046","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T12:23:34Z","timestamp":1207225414000},"page":"2073-2080","source":"Crossref","is-referenced-by-count":49,"title":["In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY)"],"prefix":"10.1016","volume":"26","author":[{"given":"El-Sayed Moustafa","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.M. Shofiqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen","family":"Van Sa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikatsu","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.02.046_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-196212000-00002","article-title":"Disseminated moniliasis in the adult","volume":"41","author":"Louria","year":"1962","journal-title":"Medicine"},{"key":"10.1016\/j.vaccine.2008.02.046_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/MMBR.44.4.660-682.1980","article-title":"Immunity of Candida albicans","volume":"44","author":"Rogers","year":"1980","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.02.046_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jn\/135.1.109","article-title":"Gastric colonization of Candida albicans differs in mice fed commercial and purified diet","volume":"135","author":"Yamaguchi","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.vaccine.2008.02.046_bib4","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1128\/AAC.44.10.2653-2658.2000","article-title":"CD4+-T-cell mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans","volume":"44","author":"Mizutani","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2008.02.046_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005792-197209000-00002","article-title":"Candida infection of the gastrointestinal tract","volume":"51","author":"Eras","year":"1972","journal-title":"Medicine"},{"key":"10.1016\/j.vaccine.2008.02.046_bib6","first-page":"13","article-title":"Candidiasis in cancer patients","volume":"77","author":"Bodey","year":"1984","journal-title":"J Med"},{"key":"10.1016\/j.vaccine.2008.02.046_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ajcp\/68.1.29","article-title":"Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology","volume":"68","author":"Myerowitz","year":"1977","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib8","first-page":"276","article-title":"Synchronous bacterial and fungal septicemia. A marker for the critically ill surgical patient","volume":"54","author":"Verghese","year":"1988","journal-title":"Am Surg"},{"key":"10.1016\/j.vaccine.2008.02.046_bib9","series-title":"Candida and candidosis: a review and bibliography","author":"Odds","year":"1988"},{"key":"10.1016\/j.vaccine.2008.02.046_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0030-4220(94)90150-3","article-title":"Animal models of oral candidiasis. A review","volume":"78","author":"Allen","year":"1994","journal-title":"Oral Surg Oral Pathol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/CMR.14.2.398-429.2001","article-title":"Experimental oral candidiasis in animal models","volume":"14","author":"Samaranayake","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.02.046_bib12","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/IAI.58.7.2228-2236.1990","article-title":"Oral and esophageal Candida albicans infection in hyposalivatory rats","volume":"58","author":"Meitner","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.02.046_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0714.1993.tb01045.x","article-title":"Effect of sialoadenectomy on the carriage of Candida albicans in the mouths of rats","volume":"22","author":"Jorge","year":"1993","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.vaccine.2008.02.046_bib14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/AAC.43.7.1621","article-title":"Multiple resistance phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients","volume":"43","author":"Lopez-Ribot","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2008.02.046_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1348-0421.2003.tb03403.x","article-title":"A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush","volume":"47","author":"Takakura","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0966-842X(01)02094-7","article-title":"Virulence factors of Candida albicans","volume":"9","author":"Calderone","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/00220345950740050301","article-title":"Oral Candida: clearance, colonization, or candidiasis?","volume":"174","author":"Cannon","year":"1995","journal-title":"J Dent Res"},{"key":"10.1016\/j.vaccine.2008.02.046_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/clinids\/14.1.340","article-title":"Fungal adherence to the vascular compartment: a critical step in the pathogenesis of the disseminated candidiasis","volume":"14","author":"Klotz","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.02.046_bib19","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","article-title":"Mechanisms of resistance azole antifungal agents in Candida albicans isolates form AIDS patients involve specific multidrug transporters","volume":"39","author":"Sanglard","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2008.02.046_bib20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDRI correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2008.02.046_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0167-5699(92)90169-8","article-title":"The role of hsp 90 in fungal infection","volume":"13","author":"Mathews","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2008.02.046_bib22","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1128\/IAI.63.11.4211-4218.1995","article-title":"Antibody immunity and invasive fungal infection","volume":"63","author":"Casadeval","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.02.046_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-302X.2005.00240.x","article-title":"Active and passive immunization against oral Candida albicans infection in a murine model","volume":"20","author":"Farah","year":"2005","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0952-7915(93)90063-X","article-title":"Homing of na\u00efve, memory and effector lymphocytes","volume":"5","author":"Mackay","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0378-1135(93)90188-D","article-title":"Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk","volume":"37","author":"Kuroki","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib26","first-page":"62","article-title":"Passive protection of dogs against clinical disease due to canine parvovirus-2 by specific antibody from chicken egg yolk","volume":"70","author":"Nguyen","year":"2006","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2008.02.046_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1128\/IAI.60.3.998-1007.1992","article-title":"Passive protective effect of chicken egg yolk immunoglobulins against experimental enterotoxigenic Escherichia coli infection in neonatal piglets","volume":"60","author":"Yokoyama","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.02.046_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1292\/jvms.59.917","article-title":"Effect of oral egg antibody in experimental F18+ Escherichia coli infection in weaned pigs","volume":"59","author":"Yokoyama","year":"1997","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2008.02.046_bib29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0264-410X(97)80916-4","article-title":"Oral passive protective immunization against experimental salmonelosis in mice using chicken egg yolk antibodies specific for Salmonella enteritidis and S. typhimurium","volume":"16","author":"Yokoyama","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.02.046_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1523-5378.2005.00290.x","article-title":"Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils","volume":"10","author":"Nomura","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.vaccine.2008.02.046_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1399-302X.2007.00358.x","article-title":"Activity of anti-Porphyromonas gingivalis egg yolk antibody against gingipains in vitro","volume":"22","author":"Yokoyama","year":"2007","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2334\/josnusd.49.201","article-title":"Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients","volume":"49","author":"Yokoyama","year":"2007","journal-title":"J Oral Sci"},{"key":"10.1016\/j.vaccine.2008.02.046_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/yea.1061","article-title":"Identification of potential cell-surface proteins in Candida albicans and investigation of the role of a putative cell-surface glycosidase in adhesion and virulence","volume":"21","author":"Alberti-Segui","year":"2004","journal-title":"Yeast"},{"key":"10.1016\/j.vaccine.2008.02.046_bib34","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1128\/AAC.47.8.2619-2623.2003","article-title":"Oral lactoferrin treatment of experimental oral candidiasis in mice","volume":"47","author":"Takakura","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2008.02.046_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000261512","article-title":"Effect of monoclonal antibodies on the colonization of rats by Streptococcus sobrinus","volume":"27","author":"van Raamsdonk","year":"1993","journal-title":"Caries Res"},{"key":"10.1016\/j.vaccine.2008.02.046_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0598-601","article-title":"Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in human","volume":"4","author":"Ma","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.02.046_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/IAI.64.2.422-427.1996","article-title":"Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis","volume":"64","author":"Booth","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.02.046_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0765.1997.tb01382.x","article-title":"Characterization of the Porphyromonas gingivalis antigen recognized by a monoclonal antibody which prevents colonization by the organism","volume":"32","author":"Booth","year":"1997","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.vaccine.2008.02.046_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1399-302X.2001.160402.x","article-title":"Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis","volume":"16","author":"Nakagawa","year":"2001","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1399-302X.2005.00220.x","article-title":"Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production","volume":"20","author":"Yonezawa","year":"2005","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib41","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.120.4.1176","article-title":"Immunologic responses to Candida albicans, III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis","volume":"120","author":"Pearsall","year":"1978","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib42","first-page":"2714","article-title":"Antibody response that protects against disseminated candidiasis","volume":"63","author":"Yongmoon","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.02.046_bib43","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/MCB.20.9.3245-3255.2000","article-title":"A novel family of cell wall-related proteins regulated differently during yeast life cycle","volume":"20","author":"Rodriguez-Pena","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2008.02.046_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.4.1.80","article-title":"Virulence factors in Escherichia coli urinary tract infection","volume":"4","author":"Johnson","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.02.046_bib45","first-page":"62","article-title":"Preparation of anti-Candida albicans antibodies in an egg-laying hen and their protective efficacy in mice","volume":"6","author":"Abdelnoor","year":"2006","journal-title":"J Appl Res"},{"key":"10.1016\/j.vaccine.2008.02.046_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1348-0421.2002.tb02700.x","article-title":"Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen","volume":"46","author":"Tansho","year":"2002","journal-title":"Microbiol Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08002326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08002326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T12:09:21Z","timestamp":1684325361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08002326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":46,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0264410X08002326"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.02.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}